Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Equity LifeStyle Properties Q3 Normalized FFO, Revenue Rise; Q4 Guidance Set

Equity LifeStyle Properties Q3 Normalized FFO, Revenue Rise; Q4 Guidance Set

MT newswireMT newswire2026/10/20 20:36
04:36 PM EDT, 10/20/2026 (MT Newswires) -- Equity LifeStyle Properties (ELS) reported Q3 normalized funds from operations late Tuesday of $0.79 per diluted share, up from $0.75 a year earlier. Analysts polled by FactSet expected $0.79. Revenue for the three months ended Sept. 30 was $409.9 million, up from $393.3 million a year earlier. Analysts surveyed by FactSet expected $402.8 million. The company expects Q4 normalized FFO of $0.78 to $0.84 per diluted share. Analysts expect $0.82. The company expects full-year 2026 normalized FFO of $3.15 to $3.21 per diluted share. Analysts expect $3.19.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss